tiprankstipranks
Trending News
More News >
Guardian Pharmacy Services, Inc. Class A (GRDN)
NYSE:GRDN
US Market
Advertisement

Guardian Pharmacy Services, Inc. Class A (GRDN) Earnings Dates, Call Summary & Reports

Compare
18 Followers

Earnings Data

Report Date
Apr 01, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.27
Last Year’s EPS
0.15
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 10, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
Guardian Pharmacy reported strong financial growth and increased guidance for the year, driven by successful acquisitions and organic growth. However, regulatory challenges and the dilutive impact of recent acquisitions present ongoing challenges. The positive financial performance and strategic expansions are tempered by these operational and external pressures.
Company Guidance
In the third quarter earnings call for 2025, Guardian Pharmacy Services reported robust financial performance, exhibiting double-digit growth across key metrics. Revenue surged by 20% to $377 million, driven by a 13% increase in resident count and strategic acquisitions. Adjusted EBITDA rose by 19% to $27 million, maintaining a margin of 7.2%. The adjusted earnings per share (EPS) stood at $0.25. Given this strong performance, Guardian raised its full-year revenue guidance to between $1.43 billion and $1.45 billion, and adjusted EBITDA guidance to between $104 million and $106 million. The company continues to navigate the policy challenges posed by the Inflation Reduction Act while focusing on organic growth, strategic acquisitions, and operational efficiencies to sustain its market leadership in serving assisted living facilities. Guardian's acquisition pipeline remains robust, with recent expansions into Oregon and Washington contributing to its growth momentum.
Revenue Growth and Financial Performance
Guardian Pharmacy reported a revenue increase of 20% to $377 million, driven by both organic growth and acquisitions. Adjusted EBITDA grew 19% to $27 million, with margins holding steady at 7.2%.
Resident Growth
The company experienced a 13% growth in resident count, reaching nearly 204,000 residents, primarily due to new facility partnerships and expansions.
Acquisitions in Pacific Northwest
Guardian Pharmacy successfully acquired pharmacies in Oregon and Washington, expanding its footprint in the Pacific Northwest and enhancing its growth potential in the region.
Increased Guidance for 2025
The company raised its full-year revenue guidance to $1.43 billion to $1.45 billion and adjusted EBITDA guidance to $104 million to $106 million, reflecting solid growth expectations.
Strong Financial Position
Guardian Pharmacy ended the quarter with $36 million in cash, highlighting strong cash generation and no debt outstanding under its credit facility.

Guardian Pharmacy Services, Inc. Class A (GRDN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

GRDN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 01, 2026
2025 (Q4)
0.27 / -
0.15
Nov 10, 2025
2025 (Q3)
0.23 / 0.25
0.275-9.09% (-0.03)
Aug 11, 2025
2025 (Q2)
0.19 / 0.23
0.245-6.12% (-0.01)
May 12, 2025
2025 (Q1)
0.22 / 0.15
0
Mar 26, 2025
2024 (Q4)
0.22 / 0.19
Nov 12, 2024
2024 (Q3)
0.19 / 0.28
0
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

GRDN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 10, 2025
$29.75$31.25+5.04%
Aug 11, 2025
$19.88$22.62+13.78%
May 12, 2025
$25.66$24.64-3.98%
Mar 26, 2025
$20.23$21.11+4.35%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Guardian Pharmacy Services, Inc. Class A (GRDN) report earnings?
Guardian Pharmacy Services, Inc. Class A (GRDN) is schdueled to report earning on Apr 01, 2026, After Close (Confirmed).
    What is Guardian Pharmacy Services, Inc. Class A (GRDN) earnings time?
    Guardian Pharmacy Services, Inc. Class A (GRDN) earnings time is at Apr 01, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is GRDN EPS forecast?
          GRDN EPS forecast for the fiscal quarter 2025 (Q4) is 0.27.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis